亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。

返回搜索结果

A Novel Index of Assessing Atherosclerosis Regression and Plaque Stabilization

详细技术说明

UC San Diego researchers have invented a novel index of atherosclerosis regression that is determined by measuring the plasma content of oxidized phospholipids. The index could provide valuable information to physicians who would use this index to measure the efficacy of treatment with statins or new anti-atherogenic drugs.

附加资料

Patent Number: US8129123B2
Application Number: US2005244300A
Inventor: Tsimikas, Sotirios | Witztum, Joseph L.
Priority Date: 5 Oct 2004
Priority Number: US8129123B2
Application Date: 5 Oct 2005
Publication Date: 6 Mar 2012
IPC Current: G01N003353
US Class: 4350071 | 43500792 | 43500794 | 436501 | 436518
Assignee Applicant: The Regents of the University of California
Title: Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios
Usefulness: Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios
Summary: The method is useful for determining whether therapy is effective for treating coronary artery disease (claimed).
Novelty: Determining whether therapy is effective for treating coronary artery disease, by determining oxidized phospholipid and apoB levels in samples obtained before and after administration of therapy, and calculating atherogenesis index

主要类别

诊断/治疗

细分类别

其他疾病

申请号码

8129123

其他

Related Materials

See the published article INNOVATION: From lab to product: a blood test's story.
Fraley AE, Schwartz GG, Olsson AG, Kinlay S, Szarek M, Rifai N, Libby P, Ganz P, Witztum JL, Tsimikas S; MIRACL Study Investigators. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering) trial. J Am Coll Cardiol. 2009 Jun 9;53(23):2186-96.

Tech ID/UC Case

19643/2005-037-0

Related Cases

2005-037-0, 2009-236-1, 2009-236-2

国家/地区

美国

欲了解更多信息，请点击这里